PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3758 (108th)

Flu Protection Act of 2004

referredUnited States· United States Congress· EN

Introduced

3 February 2004

Last action

24 February 2004 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Emanuel, Rahm [D-IL-5], JOHN SHIMKUS, Diana DeGette, ELIOT ENGEL, Rep. Snyder, Vic [D-AR-2], Rosa DeLauro, Rep. Kennedy, Patrick J. [D-RI-1], Rep. Berry, Marion [D-AR-1], Betty McCollum, Rep. Woolsey, Lynn C. [D-CA-6], Rep. Hinchey, Maurice D. [D-NY-22], GENE GREEN, Rep. Gonzalez, Charles A. [D-TX-20], Rep. Abercrombie, Neil [D-HI-1], Rep. Wexler, Robert [D-FL-19], Rep. Simmons, Rob [R-CT-2], Rep. Harman, Jane [D-CA-36], NITA LOWEY, Rep. Frank, Barney [D-MA-4], Rep. Reyes, Silvestre [D-TX-16], MIKE DOYLE, Rep. Payne, Donald M. [D-NJ-10], Marcy Kaptur, LUIS GUTIERREZ, Rep. Ackerman, Gary L. [D-NY-7], Rep. Nadler, Jerrold [D-NY-12], Rep. Filner, Bob [D-CA-51], CAROLYN MALONEY, ALCEE HASTINGS, Rep. Moran, James P. [D-VA-8]

Subjects

Healthcare, Taxation, Education

Source updated

18 August 2025

Healthcare · Taxation · Education

Official sourceDownload fileView documentsShare

Summary

Flu Protection Act of 2004 - Amends the Public Health Act to require: (1) the Secretary of Health and Human Services, through the Director of the Centers for Disease Control and Prevention, to conduct annual public influenza awareness campaign and education and outreach (including Medicare outreach) efforts preceding the flu season; (2) the Director to contract with influenza vaccine manufacturers to ensure the availability of additional doses of flu vaccine; (3) the Director to encourage States to develop a contingency immunization plan for high-risk populations in the event of a vaccine delay or shortage; and (4) the Secretary, through the Director, to establish a protocol to attempt to prevent, prepare for, and respond to an influenza epidemic or pandemic. Requires a manufacturer of a vaccine that receives Federal authority to distribute such vaccine to provide the Department of Health and Human Services (HHS) with advance notice of such manufacturer's intent to stop marketplace distribution of the vaccine. Amends the Internal Revenue Code to: (1) establish a vaccine manufacturing facilities investment tax credit (20 percent of qualifying property per year) for property placed in service by December 31, 2008; and (2) define "vaccine manufacturing facilities property."

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 3 February 2004

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 3 February 2004

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 3 February 2004

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 3 February 2004

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  5. 3 February 2004

    Introduced

    Sponsor introductory remarks on measure. (CR E105)

    Source: IntroReferral

  6. 24 February 2004

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.